Get the Daily Brief
Latest Biotech News
GSK CEO Emma Walmsley Steps Down After Transformative Nine-Year Tenure
Emma Walmsley, the first female CEO of a major pharmaceutical company, will step down as GSK’s leader at the end of 2025. Her successor, Luke Miels, currently GSK’s chief commercial officer, will...
FDA Approves Guardant Health Blood Test as Companion Diagnostic for Breast Cancer
The FDA granted approval to Guardant Health’s Guardant360 assay as a companion diagnostic to support Eli Lilly’s Inluriyo breast cancer drug. This marks the sixth companion diagnostic cleared for...
Volition and Hologic Team to Co-Market Epigenetic Profiling Service
Volition and Hologic announced a partnership to co-market Volition’s Nu.Q Discover epigenetic profiling service via Hologic’s Diagenode business. The service utilizes nucleosome quantification...
IO Biotech Halves Workforce Following FDA Setback on Cancer Vaccine Approval
IO Biotech has reduced its workforce by 50% after the FDA recommended against submitting an approval application based on failed Phase 3 melanoma trial data for their therapeutic vaccine Cylembio....
Sanofi Doubles Down on Biotech Investing with $625 Million Venture Fund Expansion
Sanofi announced a $625 million capital infusion into its corporate venture unit, Sanofi Ventures, raising total assets above $1.4 billion. The expanded evergreen fund aims to back early to...
UniQure’s Gene Therapy Shows 75% Slowing of Huntington’s Disease Progression
UniQure’s AMT-130 gene therapy delivered remarkable results, showing a statistically significant 75% slowing in Huntington's disease progression over 36 months in high-dose patients, according to...
New mRNA Vaccine Shows Promise Against Food and Seasonal Allergies
Researchers at the University of Pennsylvania and Cincinnati Children’s have developed a pioneering mRNA vaccine aiming to prevent severe allergic reactions to common foods and seasonal allergens....
New HPV Test Delivers Affordable, One-Hour Cervical Cancer Screening in Africa
A collaborative research initiative led by Rice University, Mozambique institutions, and MD Anderson Cancer Center has developed a revolutionary HPV test offering rapid results in under one hour....
Breakthrough Study Reveals Cancer Cell Stress Response as Therapeutic Target
New research uncovers the unfolded protein response (UPR) as a key adaptive mechanism enabling cancer cells to survive persistent cellular stress. Detailed in recent findings, this stress pathway...
uniQure’s Huntington’s Gene Therapy Slows Disease Progression Dramatically
UniQure has reported highly promising 36-month clinical data for AMT-130, its gene therapy candidate for Huntington’s disease (HD). The Phase I/II study demonstrated a statistically significant...
Genmab Moves to Acquire Merus for $8 Billion to Expand Cancer Pipeline
Danish biotech Genmab announced plans to acquire Dutch company Merus in an $8 billion all-cash deal. The acquisition brings Merus’s promising head and neck cancer bispecific antibody,...
MoonLake’s Stock Collapses After Mixed Results in Hidradenitis Suppurativa Trials
MoonLake Immunotherapeutics suffered a significant market value loss after its sole pipeline drug failed to meet primary endpoints in pivotal Phase 3 trials targeting hidradenitis suppurativa, an...
Sanofi Expands Venture Capital Funding with $625 Million Injection
Pharmaceutical giant Sanofi plans to augment its corporate venture arm, Sanofi Ventures, with a $625 million capital infusion, increasing assets under management to over $1.4 billion. The...
AI Enhances Real-Time Glioblastoma Diagnosis During Surgery
A team led by Harvard Medical School unveiled an AI-based tool capable of distinguishing glioblastoma from visually similar brain tumors intraoperatively with high accuracy. This advancement...
Breakthrough Biomarker Predicts Anti-CD20 Therapy Response in Multiple Sclerosis
Researchers have identified serum CST5 as a predictive marker of resistance to anti-CD20 antibody therapy in multiple sclerosis (MS) patients. Proteomic profiling of patient sera suggests CST5...
Simcere Zaiming Secures FDA IND for CDH17-Targeting Antibody-Drug Conjugate
Simcere Zaiming Pharmaceutical has achieved Investigational New Drug (IND) clearance from the FDA for SIM-0609, a novel CDH17-directed antibody-drug conjugate designed to treat advanced solid...
Novel Lectin-Based Therapeutics Target Tumor-Associated Carbohydrates Across Cancer Types
Researchers at University of California, Irvine, engineered lectin proteins that bind tumor-associated carbohydrate antigens with high affinity resembling a velcro mechanism. These lectin-based...
Groundbreaking Low-Dose Radiation Provides Relief for Knee Osteoarthritis Pain
A randomized placebo-controlled trial from South Korea demonstrated significant pain reduction in mild-to-moderate knee osteoarthritis patients following low-dose radiation therapy. This novel...
Thyme Care Raises $97 Million to Accelerate Value-Based Cancer Care Models
Thyme Care closed a $97 million Series D funding round, featuring participation from CVS Health Ventures, Foresite Capital, Morgan Health, and Humana, bringing total equity raised to $275 million....
uniQure’s Gene Therapy Yields Major Huntington’s Disease Breakthrough – Shares Surge Fivefold
uniQure announced compelling 36-month data from its Phase I/II trial of AMT-130 gene therapy for Huntington’s disease, demonstrating a 75% slowing of disease progression on the composite Unified...